Jafron Biomedical Co.,Ltd. at its Annual General Meeting of 2022 on 21 April 2023, appointed Xie Qingwu as non-independent directors, Xu Yanjun, Wen Zhihao and Guo Guoqing as independent directors and Shen Yingjuan as non-employee supervisors.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
28.93 CNY | +0.45% | -1.26% | +30.14% |
04-26 | Jafron Biomedical Co.,Ltd. Proposes Final Dividend for the Year 2023 | CI |
04-25 | Jafron Biomedical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+30.14% | 3.1B | |
-5.43% | 181B | |
+4.30% | 114B | |
-3.09% | 68.29B | |
+5.86% | 52.24B | |
+8.15% | 44.3B | |
+6.67% | 42.73B | |
+25.54% | 32.52B | |
+20.03% | 26.02B | |
+1.00% | 25.91B |
- Stock Market
- Equities
- 300529 Stock
- News Jafron Biomedical Co.,Ltd.
- Jafron Biomedical Co.,Ltd. Approves Director Elections